← All trials
NCT05888675
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2016
- Primary completion
- Oct 1, 2020
- Completion date
- Oct 1, 2020
- First posted
- Jun 5, 2023
- Last posted
- Jul 25, 2023
- Enrollment
- 72
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai University of Traditional Chinese MedicineLead sponsor
- Shanghai University of Traditional Chinese MedicineOverall official - principal investigator
- Shanghai University of Traditional Chinese MedicineReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.